378 related articles for article (PubMed ID: 11418692)
1. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
3. Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; van Maurik A; Morris PJ; Rose ML; Wood KJ
Transplantation; 2000 Sep; 70(6):955-63. PubMed ID: 11014649
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade.
Ensminger SM; Witzke O; Spriewald BM; Morrison K; Morris PJ; Rose ML; Wood KJ
Transplantation; 2000 Jun; 69(12):2609-12. PubMed ID: 10910284
[TBL] [Abstract][Full Text] [Related]
6. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
7. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
Gorbachev AV; Heeger PS; Fairchild RL
J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination.
Raisky O; Spriewald BM; Morrison KJ; Ensminger S; Mohieddine T; Obadia JF; Yacoub MH; Rose ML
J Heart Lung Transplant; 2003 Feb; 22(2):177-83. PubMed ID: 12581766
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
[TBL] [Abstract][Full Text] [Related]
10. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
11. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
12. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition.
Gorbachev AV; DiIulio NA; Fairchild RL
J Immunol; 2001 Jul; 167(1):156-62. PubMed ID: 11418644
[TBL] [Abstract][Full Text] [Related]
13. Unaltered levels of transplant arteriosclerosis in the absence of the B cell homing chemokine receptor CXCR5.
Ensminger SM; Abele-Ohl S; Ohl L; Spriewald BM; Ramsperger-Gleixner M; Weyand M; Förster R
Transpl Immunol; 2009 Mar; 20(4):218-23. PubMed ID: 19100834
[TBL] [Abstract][Full Text] [Related]
14. CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4.
Hewitson JP; Jenkins GR; Hamblin PA; Mountford AP
J Immunol; 2006 Sep; 177(5):3209-17. PubMed ID: 16920960
[TBL] [Abstract][Full Text] [Related]
15. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
17. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
18. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
19. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
20. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
Gorbachev AV; Fairchild RL
J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
